Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

about

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Item

http://www.wikidata.org/entity/Q55065461

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@en

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@nl

type

Item

label

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@en

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@nl

prefLabel

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@en

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@nl

P1476

Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

@en

P2093

Andrea Gray

http://www.w3.org/2001/XMLSchema#string

Martin Yarmush

http://www.w3.org/2001/XMLSchema#string

Rene S Schloss

http://www.w3.org/2001/XMLSchema#string

P2860

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

Interferon-gamma: an overview of signals, mechanisms and functions

Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.

The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products.

P304

201-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1142/S2339547816500084

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29732384

http://www.w3.org/2001/XMLSchema#string

P932

5932627

http://www.w3.org/2001/XMLSchema#string